BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 34272624)

  • 1. Current Understanding and Management of Intraductal Carcinoma of the Prostate.
    Considine B; Adeniran A; Hurwitz ME
    Curr Oncol Rep; 2021 Jul; 23(9):110. PubMed ID: 34272624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraductal Adenocarcinoma of the Prostate With Cribriform or Papillary Ductal Morphology: Rare Biopsy Cases Lacking Associated Invasive High-grade Carcinoma.
    Russell DH; Epstein JI
    Am J Surg Pathol; 2022 Feb; 46(2):233-240. PubMed ID: 34619708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ETS gene aberrations in atypical cribriform lesions of the prostate: Implications for the distinction between intraductal carcinoma of the prostate and cribriform high-grade prostatic intraepithelial neoplasia.
    Han B; Suleman K; Wang L; Siddiqui J; Sercia L; Magi-Galluzzi C; Palanisamy N; Chinnaiyan AM; Zhou M; Shah RB
    Am J Surg Pathol; 2010 Apr; 34(4):478-85. PubMed ID: 20220513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological analysis of intraductal proliferative lesions of prostate: intraductal carcinoma of prostate, high-grade prostatic intraepithelial neoplasia, and atypical cribriform lesion.
    Miyai K; Divatia MK; Shen SS; Miles BJ; Ayala AG; Ro JY
    Hum Pathol; 2014 Aug; 45(8):1572-81. PubMed ID: 24842280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Features and Prognostic Significance of Intraductal Carcinoma of the Prostate.
    Montironi R; Zhou M; Magi-Galluzzi C; Epstein JI
    Eur Urol Oncol; 2018 May; 1(1):21-28. PubMed ID: 31100224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical cribriform lesions of the prostate: clinical significance, differential diagnosis and current concept of intraductal carcinoma of the prostate.
    Shah RB; Zhou M
    Adv Anat Pathol; 2012 Jul; 19(4):270-8. PubMed ID: 22692290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between cribriform/intraductal prostatic adenocarcinoma and percent Gleason pattern 4 to a 22-gene genomic classifier.
    Taylor AS; Morgan TM; Wallington DG; Chinnaiyan AM; Spratt DE; Mehra R
    Prostate; 2020 Feb; 80(2):146-152. PubMed ID: 31737920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraductal carcinoma of the prostate: the whole story.
    Zhou M
    Pathology; 2013 Oct; 45(6):533-9. PubMed ID: 24018805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraductal carcinoma of the prostate: precursor or aggressive phenotype of prostate cancer?
    Bonkhoff H; Wheeler TM; van der Kwast TH; Magi-Galluzzi C; Montironi R; Cohen RJ
    Prostate; 2013 Mar; 73(4):442-8. PubMed ID: 22949099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraductal carcinoma of the prostate in the absence of high-grade invasive carcinoma represents a molecularly distinct type of in situ carcinoma enriched with oncogenic driver mutations.
    Khani F; Wobker SE; Hicks JL; Robinson BD; Barbieri CE; De Marzo AM; Epstein JI; Pritchard CC; Lotan TL
    J Pathol; 2019 Sep; 249(1):79-89. PubMed ID: 30993692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraductal Carcinoma of the Prostate Gland: Recent Advances.
    Divatia MK; Ro JY
    Yonsei Med J; 2016 Sep; 57(5):1054-62. PubMed ID: 27401634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraductal carcinoma of the prostate: interobserver reproducibility survey of 39 urologic pathologists.
    Iczkowski KA; Egevad L; Ma J; Harding-Jackson N; Algaba F; Billis A; Camparo P; Cheng L; Clouston D; Comperat EM; Datta MW; Evans AG; Griffiths DF; Guo CC; Hailemariam S; Huang W; Humphrey PA; Jiang Z; Kahane H; Kristiansen G; La Rosa FG; Lopez-Beltran A; MacLennan GT; Magi-Galluzzi C; Merrimen J; Montironi R; Osunkoya AO; Picken MM; Rao N; Shah RB; Shanks JH; Shen SS; Tawfik OW; True LD; Van der Kwast T; Varma M; Wheeler TM; Zynger DL; Sahr N; Bostwick DG
    Ann Diagn Pathol; 2014 Dec; 18(6):333-42. PubMed ID: 25263387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved Prostate Cancer Biopsy Grading by Incorporation of Invasive Cribriform and Intraductal Carcinoma in the 2014 Grade Groups.
    van Leenders GJLH; Kweldam CF; Hollemans E; Kümmerlin IP; Nieboer D; Verhoef EI; Remmers S; Incrocci L; Bangma CH; van der Kwast TH; Roobol MJ
    Eur Urol; 2020 Feb; 77(2):191-198. PubMed ID: 31439369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraductal Carcinoma of the Prostate: A Risk for Rapid Recurrence.
    Dinerman BF; Bernstein AN; Khani F; Hu JC
    Urology; 2017 Jul; 105():e1-e2. PubMed ID: 28363741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ductal, intraductal, and cribriform carcinoma of the prostate: Molecular characteristics and clinical management.
    Shi Y; Wang H; Golijanin B; Amin A; Lee J; Sikov M; Hyams E; Pareek G; Carneiro BA; Mega AE; Lagos GG; Wang L; Wang Z; Cheng L
    Urol Oncol; 2024 May; 42(5):144-154. PubMed ID: 38485644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reporting Practices and Resource Utilization in the Era of Intraductal Carcinoma of the Prostate: A Survey of Genitourinary Subspecialists.
    Gandhi JS; Smith SC; Paner GP; McKenney JK; Sekhri R; Osunkoya AO; Baras AS; DeMarzo AM; Cheville JC; Jimenez RE; Trpkov K; Colecchia M; Ro JY; Montironi R; Menon S; Hes O; Williamson SR; Hirsch MS; Netto GJ; Fine SW; Sirohi D; Kaushal S; Sangoi A; Robinson BD; Kweldam CF; Humphrey PA; Hansel DE; Schultz L; Magi-Galluzzi C; Przybycin CG; Shah RB; Mehra R; Kunju LP; Aron M; Kryvenko ON; Kench JG; Kuroda N; Tavora F; van der Kwast T; Grignon DJ; Epstein JI; Reuter VE; Amin MB
    Am J Surg Pathol; 2020 May; 44(5):673-680. PubMed ID: 31876580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneous clinicopathological features of intraductal carcinoma of the prostate: a comparison between "precursor-like" and "regular type" lesions.
    Miyai K; Divatia MK; Shen SS; Miles BJ; Ayala AG; Ro JY
    Int J Clin Exp Pathol; 2014; 7(5):2518-26. PubMed ID: 24966964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In situ and intraductal epithelial proliferations of prostate: definitions and treatment implications. Part 2: intraductal carcinoma and ductal adenocarcinoma of prostate.
    Clouston D; Bolton D
    BJU Int; 2012 Dec; 110 Suppl 4():22-4. PubMed ID: 23194119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Features and Therapeutic Outcomes in Men with Advanced Prostate Cancer and DNA Mismatch Repair Gene Mutations.
    Antonarakis ES; Shaukat F; Isaacsson Velho P; Kaur H; Shenderov E; Pardoll DM; Lotan TL
    Eur Urol; 2019 Mar; 75(3):378-382. PubMed ID: 30337059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic Features and Clinical Implications of Intraductal Carcinoma of the Prostate.
    Kang M; Lee H; Byeon SJ; Kwon GY; Jeon SS
    Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.